MedPath
HSA Approval

SPIROLON 100 TABLET 100 mg

SIN02168P

SPIROLON 100 TABLET 100 mg

SPIROLON 100 TABLET 100 mg

June 27, 1988

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C03DA01

spironolactone

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

SPIRONOLACTONE

100 mg

Spironolactone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SPIROLON 100 TABLET 100 mg - HSA Approval | MedPath